SuperworthMustang Bio shares outstanding MBIO
Diluted shares outstanding, averaged over each quarter, from 2015.
- Latest quarter, to Jun 30, 2026
- 6.7M
- On a year earlier
- +67.4%
- more shares
Mustang Bio had 6.7M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 67.4% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 6.5M | +511% |
| FY2024 | 1.1M | +428% |
| FY2023 | 200.1K | +27% |
| FY2022 | 158.2K | +29% |
| FY2021 | 122.7K | +40% |
| FY2020 | 87.9K | +65% |
| FY2019 | 53.3K | +47% |
| FY2018 | 36.2K | +4% |
| FY2017 | 34.9K | +91% |
| FY2016 | 18.3K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 6.7M | +67% | |
| Q1 FY26 | 6.7M | +135% | |
| Q4 FY25 | 6.5M | +511% | |
| Q3 FY25 | 6.2M | +766% | |
| Q2 FY25 | 4M | +800% | |
| Q1 FY25 | 2.9M | +1268% | |
| Q4 FY24 | 1.1M | +428% | |
| Q3 FY24 | 720.9K | +341% | |
| Q2 FY24 | 446.6K | +175% | |
| Q1 FY24 | 209.2K | +29% | |
| Q4 FY23 | 200.1K | +27% | |
| Q3 FY23 | 163.4K | +4% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Mustang Bio
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.